Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Total Liabilities (2023 - 2025)

Upstream Bio (UPB) has 3 years of Total Liabilities data on record, last reported at $12.6 million in Q3 2025.

  • For Q3 2025, Total Liabilities rose 3.91% year-over-year to $12.6 million; the TTM value through Sep 2025 reached $12.6 million, up 3.91%, while the annual FY2024 figure was $11.9 million, 26.39% up from the prior year.
  • Total Liabilities reached $12.6 million in Q3 2025 per UPB's latest filing, up from $11.8 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $146.6 million in Q2 2024 and bottomed at $9.4 million in Q4 2023.
  • Average Total Liabilities over 3 years is $51.2 million, with a median of $12.1 million recorded in 2024.
  • Peak YoY movement for Total Liabilities: grew 26.39% in 2024, then plummeted 92.09% in 2025.
  • A 3-year view of Total Liabilities shows it stood at $9.4 million in 2023, then rose by 26.39% to $11.9 million in 2024, then rose by 6.27% to $12.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $12.6 million in Q3 2025, $11.8 million in Q2 2025, and $10.6 million in Q1 2025.